Anaptysbio, Inc. · NASDAQ:ANAB

Fairmount Funds Management LLC reported a 5.50% stake in Anaptysbio, Inc. (Schedule 13G)

Event Dec 11, 2024 · Filed Dec 18, 2024

Fairmount Funds Management LLC reported a 5.50% stake in Anaptysbio, Inc., 1,671,484 shares, as a passive investor on Dec 11, 2024. Filed Dec 18, 2024 (Schedule 13G).

Stake
5.50%
Shares
1,671,484
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Fairmount Funds Management LLC5.50%1,671,484
Fairmount Healthcare Fund II L.P.5.50%1,671,484
Peter Harwin5.50%1,671,484
Tomas Kiselak5.50%1,671,484

Source

View original at SEC

Related